ReviewExpert opinion on emerging drugs2011

Emerging FMS-like tyrosine kinase 3 inhibitors for the treatment of acute myelogenous leukemia.

Hillary Prescott et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.